The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients
Open accessAbstract
Background— Inflammation in adipose tissue has been implicated in vascular dysfunction, but the local mechanisms by which this occurs are unknown. Methods and Results— Small arteries with and without perivascular adipose tissue were taken from subcutaneous gluteal fat biopsy samples and studied with wire myography and immunohistochemistry. We established that healthy adipose tissue around human small arteries secretes factors that influence vasodilation by increasing nitric oxide bioavailability. However, in perivascular fat from obese subjects with metabolic syndrome (waist circumference 111±2.8 versus 91.1±3.5 cm in control subjects, P <0.001; insulin sensitivity 41±5.9% versus 121±18.6% in control subjects, P <0.001), the loss of this dilator effect was accompanied by an increase in adipocyte area (1786±346 versus 673±60 μm 2 , P <0.01) and immunohistochemical evidence of inflammation (tumor necrosis factor receptor 1 12.4±1.1% versus 6.7±1%, P <0.001). Application of the cytokines tumor necrosis factor receptor-α and interleukin-6 to perivascular fat around healthy blood vessels reduced dilator activity, resulting in the obese phenotype. These effects could be reversed with free radical scavengers or cytokine antagonists. Similarly, induction of hypoxia stimulated inflammation and resulted in loss of anticontractile capacity, which could be rescued by catalase and superoxide dismutase or cytokine antagonists. Incubation with a soluble fragment of adiponectin type 1 receptor or inhibition of nitric oxide synthase blocked the vasodilator effect of healthy perivascular adipose tissue. Conclusions— We conclude that adipocytes secrete adiponectin and provide the first functional evidence that it is a physiological modulator of local vascular tone by increasing nitric oxide bioavailability. This capacity is lost in obesity by the development of adipocyte hypertrophy, leading to hypoxia, inflammation, and oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Mulvany, M. J., & Halpern, W. (1977) · Circulation Research · doi:10.1161/01.res.41.1.19 · Cited by 2,140
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 2×
“Incubations performed for arteries with and without PVAT included the following: (1) Adiponectin blocking peptide; (2) single cytokines (TNF, IL-6, or IL-1); (3) TNF and anti-TNF blocking antibody; (4) IL-6 and IL-6 blocking antibody; (5) IL-6 and TNF, followed by incubation with superoxide dismutase and catalase, fol…”
MethodAdiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin
Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T.-S., & Lodish, H. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403382101 · Cited by 859
Hunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662 · cited 1×
“Incubations performed for arteries with and without PVAT included the following: (1) Adiponectin blocking peptide; (2) single cytokines (TNF, IL-6, or IL-1); (3) TNF and anti-TNF blocking antibody; (4) IL-6 and IL-6 blocking antibody; (5) IL-6 and TNF, followed by incubation with superoxide dismutase and catalase, fol…”
MethodYudkin, J. S., Eringa, E., & Stehouwer, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66585-3 · Cited by 549
Periadventitial fat releases a vascular relaxing factor
LÖHN, M., DUBROVSKA, G., LAUTERBACH, B., LUFT, F. C., GOLLASCH, M., & SHARMA, A. M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0024com · Cited by 472
Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?
Trayhurn, P., Wang, B., & Wood, I. S. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508971282 · Cited by 464
Influence of Perivascular Adipose Tissue on Rat Aortic Smooth Muscle Responsiveness
Soltis, E. E., & Cassis, L. A. (1991) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641969109042063 · Cited by 382
Gao, Y., Lu, C., Su, L., Sharma, A. M., & Lee, R. M. K. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707228 · Cited by 322
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., Spohr, C., Kober, L., Vaag, A., & Torp-Pedersen, C. (2005) · Journal of Vascular Research · doi:10.1159/000088261 · Cited by 286
Visceral Periadventitial Adipose Tissue Regulates Arterial Tone of Mesenteric Arteries
Verlohren, S., Dubrovska, G., Tsang, S.-Y., Essin, K., Luft, F. C., Huang, Y., & Gollasch, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000140058.28994.ec · Cited by 278
Adiponectin is a novel humoral vasodilator
FESUS, G., DUBROVSKA, G., GORZELNIAK, K., KLUGE, R., HUANG, Y., LUFT, F., & GOLLASCH, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.025 · Cited by 275
Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system
Halpern, W., Osol, G., & Coy, G. S. (1984) · Annals of Biomedical Engineering · doi:10.1007/bf02363917 · Cited by 265
Adiponectin, Cardiovascular Function, and Hypertension
Wang, Z. V., & Scherer, P. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.099424 · Cited by 247
Chen, B., Lam, K. S. L., Wang, Y., Wu, D., Lam, M. C., Shen, J., Wong, L., Hoo, R. L. C., Zhang, J., & Xu, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.004 · Cited by 238
Wang, B., Jenkins, J. R., & Trayhurn, P. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00475.2004 · Cited by 233
Winkler, G., Kiss, S., Keszthelyi, L., Sapi, Z., Ory, I., Salamon, F., Kovacs, M., Vargha, P., Szekeres, O., Speer, G., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490129 · Cited by 213
Perivascular adipose tissue modulates vascular function in the human internal thoracic artery
Gao, Y.-J., Zeng, Z.-H., Teoh, K., Sharma, A. M., Abouzahr, L., Cybulsky, I., Lamy, A., Semelhago, L., & Lee, R. M. K. W. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.05.028 · Cited by 189
Abdominal Adiposity and Cardiometabolic Risk: Do We Have All the Answers?
Haffner, S. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.006 · Cited by 188
Mechanisms of ADRF release from rat aortic adventitial adipose tissue
Dubrovska, G., Verlohren, S., Luft, F. C., & Gollasch, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00656.2003 · Cited by 165
Paracrine role for periadventitial adipose tissue in the regulation of arterial tone
Gollasch, M., & Dubrovska, G. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.005 · Cited by 160
Lind, L., & Lithell, H. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90446-g · Cited by 132
Gao, Y.-J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039634 · Cited by 130
Hube, Birgel, Lee, & Hauner (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00520.x · Cited by 112
Hamburg, N. M., Larson, M. G., Vita, J. A., Vasan, R. S., Keyes, M. J., Widlansky, M. E., Fox, C. S., Mitchell, G. F., Levy, D. A., Meigs, J. B., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.053 · Cited by 107
Malinowski, M., Deja, M. A., Golba, K. S., Roleder, T., Biernat, J., & Woś, S. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.11.007 · Cited by 87
de Jongh, R. T., IJzerman, R. G., Serné, E. H., Voordouw, J. J., Yudkin, J. S., de Waal, H. A. D., Stehouwer, C. D. A., & van Weissenbruch, M. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1103 · Cited by 84
Variability in Response to Antihypertensive Drugs
Materson, B. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.02.003 · Cited by 82
Yates, A. P., & Laing, I. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00644.x · Cited by 67
Self-citationWimalasundera, R. C., Fexby, S. E., Regan, L., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705168 · Cited by 65
Hube, F., & Hauner, H. (2000) · Endocrinology · doi:10.1210/endo.141.7.7561 · Cited by 48
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Obokata, M., Reddy, Y. N. V., Pislaru, S. V., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.026807 · Cited by 1,179
Obesity, Adipose Tissue and Vascular Dysfunction
Koenen, M., Hill, M. A., Cohen, P., & Sowers, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318093 · Cited by 904
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Metadata
- Authors
- Greenstein, A. S., Khavandi, K., Withers, S. B., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., & Heagerty, A. M.
- Venue
- Circulation
- Published
- 2009-03-31
- Volume
- 119
- Issue
- 12
- Pages
- 1661-1670
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2029632724
- Cited by
- 618
- References
- 40
- FWCI
- 19.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.